62 research outputs found

    Dynamics of Droplets Impacting on Aerogel, Liquid Infused, and Liquid-Like Solid Surfaces

    Get PDF
    Droplets impacting superhydrophobic surfaces have been extensively studied due to their compelling scientific insights and important industrial applications. In these cases, the commonly reported impact regime was that of complete rebound. This impact regime strongly depends on the nature of the superhydrophobic surface. Here, we report the dynamics of droplets impacting three hydrophobic slippery surfaces, which have fundamental differences in normal liquid adhesion and lateral static and kinetic liquid friction. For an air cushion-like (super)hydrophobic solid surface (Aerogel) with low adhesion and low static and low kinetic friction, complete rebound can start at a very low Weber (We) number (∌1). For slippery liquid-infused porous (SLIP) surfaces with high adhesion and low static and low kinetic friction, complete rebound only occurs at a much higher We number (>5). For a slippery omniphobic covalently attached liquid-like (SOCAL) solid surface, with high adhesion and low static friction similar to SLIPS but higher kinetic friction, complete rebound was not observed, even for a We as high as 200. Furthermore, the droplet ejection volume after impacting the Aerogel surface is 100% across the whole range of We numbers tested compared to other surfaces. In contrast, droplet ejection for SLIPs was only observed consistently when the We was above 5–10. For SOCAL, 100% (or near 100%) ejection volume was not observed even at the highest We number tested here (∌200). This suggests that droplets impacting our (super)hydrophobic Aerogel and SLIPS lose less kinetic energy. These insights into the differences between normal adhesion and lateral friction properties can be used to inform the selection of surface properties to achieve the most desirable droplet impact characteristics to fulfill a wide range of applications, such as deicing, inkjet printing, and microelectronics

    Slippery Liquid-Like Solid Surfaces with Promising Antibiofilm Performance in both Static and Flow Conditions

    Get PDF
    [Image: see text] Biofilms are central to some of the most urgent global challenges across diverse fields of application, from medicine to industries to the environment, and exert considerable economic and social impact. A fundamental assumption in anti-biofilms has been that the coating on a substrate surface is solid. The invention of slippery liquid-infused porous surfaces—a continuously wet lubricating coating retained on a solid surface by capillary forces—has led to this being challenged. However, in situations where flow occurs, shear stress may deplete the lubricant and affect the anti-biofilm performance. Here, we report on the use of slippery omniphobic covalently attached liquid (SOCAL) surfaces, which provide a surface coating with short (ca. 4 nm) non-cross-linked polydimethylsiloxane (PDMS) chains retaining liquid–surface properties, as an antibiofilm strategy stable under shear stress from flow. This surface reduced biofilm formation of the key biofilm-forming pathogens Staphylococcus epidermidis and Pseudomonas aeruginosa by three–four orders of magnitude compared to the widely used medical implant material PDMS after 7 days under static and dynamic culture conditions. Throughout the entire dynamic culture period of P. aeruginosa, SOCAL significantly outperformed a typical antibiofilm slippery surface [i.e., swollen PDMS in silicone oil (S-PDMS)]. We have revealed that significant oil loss occurred after 2–7 day flow for S-PDMS, which correlated to increased contact angle hysteresis (CAH), indicating a degradation of the slippery surface properties, and biofilm formation, while SOCAL has stable CAH and sustainable antibiofilm performance after 7 day flow. The significance of this correlation is to provide a useful easy-to-measure physical parameter as an indicator for long-term antibiofilm performance. This biofilm-resistant liquid-like solid surface offers a new antibiofilm strategy for applications in medical devices and other areas where biofilm development is problematic

    Antiwetting and Antifouling Performances of Different Lubricant-Infused Slippery Surfaces

    Get PDF
    The concept of slippery lubricant-infused surfaces has shown promising potential in antifouling for controlling detrimental biofilm growth. In this study, nontoxic silicone oil was either impregnated into porous surface nanostructures, referred to as liquid-infused surfaces (LIS), or diffused into a polydimethylsiloxane (PDMS) matrix, referred to as a swollen PDMS (S-PDMS), making two kinds of slippery surfaces. The slippery lubricant layers have extremely low contact angle hysteresis, and both slippery surfaces showed superior antiwetting performances with droplets bouncing off or rolling transiently after impacting the surfaces. We further demonstrated that water droplets can remove dust from the slippery surfaces, thus showing a “cleaning effect”. Moreover, “coffee-ring” effects were inhibited on these slippery surfaces after droplet evaporation, and deposits could be easily removed. The clinically biofilm-forming species P. aeruginosa (as a model system) was used to further evaluate the antifouling potential of the slippery surfaces. The dried biofilm stains could still be easily removed from the slippery surfaces. Additionally, both slippery surfaces prevented around 90% of bacterial biofilm growth after 6 days compared to the unmodified control PDMS surfaces. This investigation also extended across another clinical pathogen, S. epidermidis, and showed similar results. The antiwetting and antifouling analysis in this study will facilitate the development of more efficient slippery platforms for controlling biofouling

    The Chemical Composition and Nitrogen Distribution of Chinese Yak (Maiwa) Milk

    Get PDF
    The paper surveyed the chemical composition and nitrogen distribution of Maiwa yak milk, and compared the results with reference composition of cow milk. Compared to cow milk, yak milk was richer in protein (especially whey protein), essential amino acids, fat, lactose and minerals (except phosphorus). The contents of some nutrients (total protein, lactose, essential amino acids and casein) were higher in the warm season than in the cold season. Higher ratios of total essential amino acids/total amino acids (TEAA/TAA) and total essential amino acids/total non essential amino acids (TEAA/TNEAA) were found in the yak milk from the warm season. However its annual average ratio of EAA/TAA and that of EAA/NEAA were similar to those of cow milk. Yak milk was rich in calcium and iron (p < 0.05), and thus may serve as a nutritional ingredient with a potential application in industrial processing

    Where should siRNAs go: applicable organs for siRNA drugs

    No full text
    Abstract RNA interference mediated by small interfering RNAs (siRNAs) has been exploited for the development of therapeutics. siRNAs can be a powerful therapeutic tool because the working mechanisms of siRNAs are straightforward. siRNAs determine targets based on their sequence and specifically regulate the gene expression of the target gene. However, efficient delivery of siRNAs to the target organ has long been an issue that needs to be solved. Tremendous efforts regarding siRNA delivery have led to significant progress in siRNA drug development, and from 2018 to 2022, a total of five siRNA drugs were approved for the treatment of patients. Although all FDA-approved siRNA drugs target the hepatocytes of the liver, siRNA-based drugs targeting different organs are in clinical trials. In this review, we introduce siRNA drugs in the market and siRNA drug candidates in clinical trials that target cells in multiple organs. The liver, eye, and skin are the preferred organs targeted by siRNAs. Three or more siRNA drug candidates are in phase 2 or 3 clinical trials to suppress gene expression in these preferred organs. On the other hand, the lungs, kidneys, and brain are challenging organs with relatively few clinical trials. We discuss the characteristics of each organ related to the advantages and disadvantages of siRNA drug targeting and strategies to overcome the barriers in delivering siRNAs based on organ-specific siRNA drugs that have progressed to clinical trials

    Intragenic L1 Insertion: One Possibility of Brain Disorder

    No full text
    Long interspersed nuclear element 1 (LINE1, L1) is a retrotransposon comprising ~17% of the human genome. A subset of L1s maintains the potential to mobilize and alter the genomic landscape, consequently contributing to the change in genome integrity and gene expression. L1 retrotransposition occurs in the human brain regardless of disease status. However, in the brain of patients with various brain diseases, the expression level and copy number of L1 are significantly increased. In this review, we briefly introduce the methodologies applied to measure L1 mobility and identify genomic loci where new insertion of L1 occurs in the brain. Then, we present a list of genes disrupted by L1 transposition in the genome of patients with brain disorders. Finally, we discuss the association between genes disrupted by L1 and relative brain disorders

    Biogenesis of small RNAs in animals

    No full text
    Small RNAs of 20-30 nucleotides can target both chromatin and transcripts, and thereby keep both the genome and the transcriptome under extensive surveillance. Recent progress in high-throughput sequencing has uncovered an astounding landscape of small RNAs in eukaryotic cells. Various small RNAs of distinctive characteristics have been found and can be classified into three classes based on their biogenesis mechanism and the type of Argonaute protein that they are associated with: microRNAs (miRNAs), endogenous small interfering RNAs (endo-siRNAs or esiRNAs) and Piwi-interacting RNAs (piRNAs). This Review summarizes our current knowledge of how these intriguing molecules are generated in animal cells

    The enemy within: intronic miR-26b represses its host gene, ctdsp2, to regulate neurogenesis

    No full text
    Stem cell differentiation is a highly coordinated process, and in this Perspective, Gage and colleagues highlight a study that reports a novel mechanism regulating neural differentiation (Dill and colleagues, in this issue). The authors discuss the finding that REST, a transcriptional regulator in neuronal stem cells that complexes with a CTDSP (a group of phosphatases), can be regulated by an intronic microRNA, miR-26b
    • 

    corecore